Home/Filings/4/0001562180-23-000343
4//SEC Filing

Pine Michael Craig 4

Accession 0001562180-23-000343

CIK 0001314102other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 5:51 PM ET

Size

5.7 KB

Accession

0001562180-23-000343

Insider Transaction Report

Form 4
Period: 2023-01-06
Pine Michael Craig
Chief Corp Dev.&Strat. Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-06+91,65591,655 total
    Exercise: $3.26Exp: 2033-01-05Common Stock (91,655 underlying)
Footnotes (1)
  • [F1]The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years.

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

Related Parties

1
  • filerCIK 0001904458

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 5:51 PM ET
Size
5.7 KB